1. Home
  2. UPC vs ALZN Comparison

UPC vs ALZN Comparison

Compare UPC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • ALZN
  • Stock Information
  • Founded
  • UPC 1998
  • ALZN 2016
  • Country
  • UPC China
  • ALZN United States
  • Employees
  • UPC N/A
  • ALZN N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • ALZN Medicinal Chemicals and Botanical Products
  • Sector
  • UPC Health Care
  • ALZN Health Care
  • Exchange
  • UPC Nasdaq
  • ALZN Nasdaq
  • Market Cap
  • UPC 2.0M
  • ALZN 2.3M
  • IPO Year
  • UPC 2021
  • ALZN 2021
  • Fundamental
  • Price
  • UPC $3.75
  • ALZN $3.19
  • Analyst Decision
  • UPC
  • ALZN Strong Buy
  • Analyst Count
  • UPC 0
  • ALZN 1
  • Target Price
  • UPC N/A
  • ALZN $180.00
  • AVG Volume (30 Days)
  • UPC 25.4K
  • ALZN 239.8K
  • Earning Date
  • UPC 07-25-2025
  • ALZN 09-10-2025
  • Dividend Yield
  • UPC N/A
  • ALZN N/A
  • EPS Growth
  • UPC N/A
  • ALZN N/A
  • EPS
  • UPC N/A
  • ALZN N/A
  • Revenue
  • UPC $19,293,003.00
  • ALZN N/A
  • Revenue This Year
  • UPC N/A
  • ALZN $322.64
  • Revenue Next Year
  • UPC N/A
  • ALZN N/A
  • P/E Ratio
  • UPC N/A
  • ALZN N/A
  • Revenue Growth
  • UPC N/A
  • ALZN N/A
  • 52 Week Low
  • UPC $2.51
  • ALZN $2.75
  • 52 Week High
  • UPC $2,465.94
  • ALZN $135.54
  • Technical
  • Relative Strength Index (RSI)
  • UPC 45.46
  • ALZN 45.71
  • Support Level
  • UPC $3.54
  • ALZN $2.95
  • Resistance Level
  • UPC $3.96
  • ALZN $3.35
  • Average True Range (ATR)
  • UPC 0.21
  • ALZN 0.16
  • MACD
  • UPC 0.04
  • ALZN 0.09
  • Stochastic Oscillator
  • UPC 62.02
  • ALZN 64.17

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: